Direct Selling Acquisition Corp. - Quarter Report: 2023 March (Form 10-Q)
Table of Contents
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware |
001-40831 |
86-3676785 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant |
DSAQ.U |
New York Stock Exchange | ||
Class A common stock, par value $0.0001 per share |
DSAQ |
New York Stock Exchange | ||
Redeemable warrants, each warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share |
DSAQ.W |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ☒ | |||
Emerging growth company | ☒ |
Table of Contents
DIRECT SELLING ACQUISITION CORP.
Form 10-Q For the Quarter Ended March 31, 2023
Table of Contents
Table of Contents
March 31, 2023 |
December 31, 2022 |
|||||||
(Unaudited) |
||||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | 1,369,435 | $ | 1,151,319 | ||||
Prepaid expenses |
99,649 | 114,915 | ||||||
Total current assets |
1,469,084 |
1,266,234 |
||||||
Investments held in Trust Account |
59,316,972 | 239,365,794 | ||||||
Total Assets |
$ |
60,786,056 |
$ |
240,632,028 |
||||
Liabilities, Redeemable Common Stock and Stockholders’ Deficit |
||||||||
Liabilities: |
||||||||
Franchise taxes payable |
$ | 50,000 | $ | 68,880 | ||||
Federal income taxes payable |
1,152,567 | 646,912 | ||||||
Due to related party |
667 | 667 | ||||||
Promissory notes to related party |
3,135,719 | 2,300,000 | ||||||
Accounts payable and accrued expenses |
233,699 | 432,844 | ||||||
Total current liabilities |
4,572,652 |
3,449,303 |
||||||
Warrant liability |
1,856,000 | 928,000 | ||||||
Deferred underwriters’ discount |
8,050,000 | 8,050,000 | ||||||
Total Liabilities |
14,478,652 |
12,427,303 |
||||||
Commitments and Contingencies (Note 6) |
||||||||
Redeemable Class A common stock subject to possible redemption, 5,595,494 and 23,000,000 shares at redemption value at March 31, 2023 and December 31, 2022, respectively |
59,199,429 | 239,285,445 | ||||||
Stockholders’ Deficit: |
||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding |
— | — | ||||||
Class A common stock, $0.0001 par value; 380,000,000 shares authorized; none issued or outstanding (excluding 5,595,494 and 23,000,000 shares subject to redemption at March 31, 2023 and December 31, 2022, respectively) |
— | — | ||||||
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 5,750,000 shares issued and outstanding |
575 | 575 | ||||||
Additional paid-in capital |
— | — | ||||||
Accumulated deficit |
(12,892,600 | ) | (11,081,295 | ) | ||||
Total Stockholders’ Deficit |
(12,892,025 |
) |
(11,080,720 |
) | ||||
Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit |
$ |
60,786,056 |
$ |
240,632,028 |
||||
For the three months ended March 31, |
||||||||
2023 |
2022 |
|||||||
Operating costs |
$ | 461,977 | $ | 792,281 | ||||
|
|
|
|
|||||
Loss from operations |
(461,977 |
) |
(792,281 |
) | ||||
Other income: |
||||||||
Bank interest income |
8,133 | 25 | ||||||
Interest earned on investments held in Trust Account |
2,450,287 | 20,880 | ||||||
Change in fair value of warrant liability |
(928,000 | ) | 5,800,000 | |||||
|
|
|
|
|||||
Total other income, net |
1,530,420 |
5,820,905 |
||||||
|
|
|
|
|||||
Income before provision for income taxes |
1,068,443 | 5,028,624 | ||||||
Provision for income taxes |
(505,655 | ) | — | |||||
|
|
|
|
|||||
Net income |
$ |
562,788 |
$ |
5,028,624 |
||||
|
|
|
|
|||||
Weighted average shares outstanding of Class A common stock |
21,259,549 | 23,000,000 | ||||||
|
|
|
|
|||||
Basic and diluted net income per share, Class A common stock |
$ |
(0.07 |
) |
$ |
0.17 |
|||
|
|
|
|
|||||
Weighted average shares outstanding of Class B common stock |
5,750,000 | 5,750,000 | ||||||
|
|
|
|
|||||
Basic and diluted net income per share, Class B common stock |
$ |
(0.07 |
) |
$ |
0.17 |
|||
|
|
|
|
Class B common stock |
Ad ditional |
Accumulated |
Total Stockholders’ |
|||||||||||||||||
Shares |
Amount |
Paid-in Capital |
Deficit |
Deficit |
||||||||||||||||
Balance as of December 31, 2022 |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(11,081,295 |
) |
$ |
(11,080,720 |
) | |||||||||
Accretion of carrying value to redemption value |
— | — | — | (2,374,093 | ) | (2,374,093 | ) | |||||||||||||
Net income |
— | — | — | 562,788 | 562,788 | |||||||||||||||
Balance as of March 31, 2023 (unaudited) |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(12,892,600 |
) |
$ |
(12,892,025 |
) | |||||||||
Class B common stock |
Additional |
Accumulated |
Total Stockholders’ |
|||||||||||||||||
Shares |
Amount |
Paid-in Capital |
Deficit |
Deficit |
||||||||||||||||
Balance as of December 31, 2021 |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(17,974,760 |
) |
$ |
(17,974,185 |
) | |||||||||
Net income |
— | — | — | 5,028,624 | 5,028,624 | |||||||||||||||
Balance as of March 31, 2022 (unaudited) |
5,750,000 |
$ |
575 |
$ |
— |
$ |
(12,946,136 |
) |
$ |
(12,945,561 |
) | |||||||||
For the three months ended March 31, 2023 |
For the three months ended March 31, 2022 |
|||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 562,788 | $ | 5,028,624 | ||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Change in fair value of warrant liability |
928,000 | (5,800,000 | ) | |||||
Interest earned on investments held in Trust Account |
(2,450,287 | ) | (20,880 | ) | ||||
Changes in current assets and liabilities: |
||||||||
Prepaid assets |
15,266 | 183,481 | ||||||
Taxes payable |
486,775 | (10,274 | ) | |||||
Accrued offering costs and expenses |
(199,145 | ) | 286,849 | |||||
Net cash used in operating activities |
(656,603 |
) |
(332,200 |
) | ||||
Cash flows from investing activities: |
||||||||
Withdraw from Trust Account to pay taxes |
519,000 | — | ||||||
Withdraw from Trust Account for redemptions of stock |
182,460,109 | — | ||||||
Funding of Trust Account |
(480,000 | ) | — | |||||
Net cash provided by investing activities |
182,499,109 |
— |
||||||
Cash flows from financing activities: |
||||||||
Funds withdrawn for redemptions |
(182,460,109 | ) | — | |||||
Proceeds from issuance of promissory note to related party |
835,719 | — | ||||||
Net cash used in financing activities |
(181,624,390 |
) |
— |
|||||
Net change in cash |
218,116 |
(332,200 |
) | |||||
Cash, beginning of the period |
1,151,319 | 1,041,948 | ||||||
Cash, end of the period |
$ |
1,369,435 |
$ |
709,748 |
||||
Supplemental disclosure of non-cash financing activities: |
||||||||
Accretion of carrying value to redemption value |
$ | 2,374,093 | $ | — | ||||
For the three months ended March 31, 2023 |
For the three months ended March 31, 2022 |
|||||||
Net income |
$ | 562,788 | $ | 5,028,624 | ||||
Accretion of temporary equity to redemption value |
(2,374,093 | ) | — | |||||
|
|
|
|
|||||
Net income (loss) including accretion of temporary equity to redemption value |
$ | (1,811,305 | ) | $ | 5,028,624 | |||
|
|
|
|
For the Three Months Ended March 31, |
||||||||||||||||
2023 |
2022 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic and diluted net (loss) income per share of common stock: |
||||||||||||||||
Numerator: |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Allocation of net (loss) income |
$ | (1,425,701 | ) | $ | (385,604 | ) | $ | 4,022,899 | $ | 1,005,725 | ||||||
|
|
|
|
|
|
|
|
|||||||||
Denominator: |
||||||||||||||||
Weighted-average shares outstanding |
21,259,549 | 5,750,000 | 23,000,000 | 5,750,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net (loss) income per common stock |
$ | (0.07 | ) | $ | (0.07 | ) | $ | 0.17 | $ | 0.17 | ||||||
|
|
|
|
|
|
|
|
• | Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• | Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• | Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
Contingently redeemable common stock at January 1, 2022 |
$ |
234,600,000 |
||
Plus: |
||||
Accretion to redemption value from earnings |
2,385,445 | |||
Accretion to redemption value from additional funding |
2,300,000 | |||
Contingently redeemable common stock at December 31, 2022 |
239,285,445 |
|||
Less: |
||||
Redemptions |
(182,460,109 | ) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
1,894,093 | |||
Accretion to redemption value from additional funding |
480,000 | |||
Contingently redeemable common stock at March 31, 2023 |
$ |
59,199,429 |
• | in whole and not in part; |
• | at a price of $0.01 per warrant; |
• | upon not less than 30 days’ prior written notice of redemption to each warrant holder; and |
• | if, and only if, the closing price of the common stock equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant for any 20 trading days within a 30-trading day period ending trading days before the Company sends the notice of redemption to the warrant holders. |
March 31, 2023 |
||||||||||||
Level 1 |
Level 2 |
Level 3 |
||||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
$ | 59,316,972 | $ | — | $ | — | ||||||
Liabilities: |
||||||||||||
Working Capital Loan Conversion Option |
$ | — | $ | — | $ | — | ||||||
Public Warrants |
920,000 | — | — | |||||||||
Private Placement Warrants |
— | 936,000 | — | |||||||||
$ | 920,000 | $ | 936,000 | $ | — | |||||||
December 31, 2022 |
||||||||||||
Level 1 |
Level 2 |
Level 3 |
||||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
$ | 239,365,794 | $ | — | $ | — | ||||||
Liabilities: |
||||||||||||
Working Capital Loan Conversion Option |
$ | — | $ | — | $ | — | ||||||
Public Warrants |
460,000 | — | — | |||||||||
Private Placement Warrants |
— | 468,000 | — | |||||||||
$ | 460,000 | $ | 468,000 | $ | — | |||||||
Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
References to the “Company,” “Direct Selling Acquisition Corp.,” “our,” “us” or “we” refer to Direct Selling Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.
Overview
We are a blank check company formed under the laws of the State of Delaware on March 9, 2021, for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash from the proceeds of the Public Offering and the sale of the Private Placement Warrants, our capital stock, debt or a combination of cash, stock and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
On March 24, 2023 our stockholders voted to amend our amended and restated certificate of incorporation (the “Charter”) to extend the date (the “Termination Date”) by which we have to consummate a Business Combination (the “Charter Extension”) from March 28, 2023 (the “Original Termination Date”) to June 28, 2023 (the “Charter Extension Date”) and to allow the Company, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to nine times by an additional one month each time after the Charter Extension Date, by resolution of our board of directors (the “Board”), if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until March 28, 2024 (each, an “Additional Charter Extension Date”) or a total of up to twelve months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Extension Amendment Proposal”). For each monthly extension of the Charter Extension Date we will deposit $160,000 into the Trust Account. For the three months ended March 31, 2023, $480,000 has been deposited in the Trust Account to extend the Termination Date to June 28, 2023.
In connection with the vote of our stockholders on March 24, 2023 to extend our Termination Date, the holders of 17,404,506 Class A common stock of the Company properly exercised their right to redeem their shares for an aggregate price of approximately $10.48 per share, for an aggregate redemption amount of $182,460,110. After the satisfaction of such redemptions, the balance in our trust account was $58,660,352 (including interest not previously released to the Company but net of expected franchise and income taxes payable).
Liquidity and Capital Resources
As of March 31, 2023, we had $1,369,435 in our operating bank account and working capital deficit of $1,901,001 (excluding income and Delaware franchise taxes).
In order to finance transaction costs in connection with a Business Combination or any extension of the deadline by which the Company must consummate its initial Business Combination or liquidate, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans. The Company has entered into promissory notes (“Promissory Notes”) with the Sponsor for a total of $3,135,719. These Notes bear no interest and are due upon liquidation or consummation of an initial Business Combination. If the Company completes an initial Business Combination, the Company would repay such loaned amounts out of the proceeds of the Trust Account released to the Company. Otherwise, such loans would be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used to repay such loaned amounts. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant at the option of the lender.
It is uncertain that we will be able to consummate an initial business combination within 12 months from the issuance date of these financial statements or obtain additional loans from the Sponsor. If an initial Business Combination is not consummated by the required date of June 28, 2023, there will be a mandatory liquidation and subsequent dissolution. In the event of a dissolution, we anticipate a shortfall of liquidity. Our anticipated shortfall of sufficient liquidity to meet our current and future estimated financial obligations raises substantial doubt about our ability to continue as a going concern for a period of time within one year after the date that the accompanying financial statements are issued. We plan to address this uncertainty through loans and through consummation of our initial Business Combination. There is no assurance that loans will be available to us or that our plans to consummate an initial Business Combination will be successful.
18
Table of Contents
Off-Balance Sheet Arrangements
As of March 31, 2023, we did not have any off-balance sheet arrangements.
Risks and Uncertainties
Management is currently evaluating the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, rising trade tensions between the United States and China, and other uncertainties regarding actual and potential shifts in the U.S. and foreign trade, economic and other policies with other countries, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Specifically, the conflict between Russia and Ukraine and resulting market volatility could adversely affect the Company’s ability to complete a Business Combination. In response to the conflict between Russia and Ukraine, the U.S. and other countries have imposed sanctions or other restrictive actions against Russia. Any of the above factors, including sanctions, export controls, tariffs, trade wars and other governmental actions, could have a material adverse effect on the Company’s ability to complete a Business Combination and the value of the Company’s securities.
In addition, we depend on a variety of U.S. and multi-national financial institutions to provide us with banking services. The default or failure of one or more of the financial institutions that we rely on may adversely affect our business and financial condition, including our ability to successfully consummate a Business Combination.
We maintain the majority of our cash and cash equivalents in accounts with major U.S. and multi-national financial institutions, and our deposits at certain of these institutions exceed insured limits. Market conditions can impact the viability of these institutions. In the event of the failure of any of the financial institutions where we maintain our cash and cash equivalents, there can be no assurance that we would be able to access uninsured funds in a timely manner or at all. Any inability to access or delay in accessing these funds could adversely affect our liquidity, business and financial condition.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions and economically similar transactions) of stock by publicly traded U.S. corporations on or after January 1, 2023. Because we are a Delaware corporation and our securities are trading on the New York Stock Exchange, we are a “covered corporation” within the meaning of the IR Act. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased (although it may reduce the amount of cash distributable in a current or subsequent redemption). The amount of the excise tax is generally 1% of the fair market value of the shares repurchased, determined at the time of the repurchase. Corporations are permitted to net the fair market value of certain new stock issuances by such corporation against the fair market value of stock repurchases (or deemed repurchases) during the same taxable year to reduce or eliminate the amount of excise tax that would otherwise apply. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has authority to provide regulations and other guidance to carry out, and prevent the abuse or avoidance of, the excise tax.
On December 27, 2022, the Treasury published Notice 2023-2 as interim guidance until the publication of forthcoming proposed regulations on the excise tax. Nevertheless, it remains uncertain whether, and/or to what extent, the excise tax could apply to redemptions of our stock, including any redemptions in connection with a Business Combination, or in the event we do not consummate a Business Combination.
19
Table of Contents
Because the application of the excise tax is not entirely clear, any share redemption or other share repurchase may be subject to the excise tax. Whether and to what extent we would be subject to the excise tax will depend on a number of factors, including (i) whether the redemption is treated as a repurchase of stock for purposes of the excise tax, (ii) the fair market value of the redemptions treated as repurchases in connection with a Business Combination, (iii) the structure of a Business Combination and whether any such transaction closes, (iv) the nature and amount of any private investment in public equity (“PIPE”) or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination), (v) whether we consummate a Business Combination, and (vi) the content of regulations and other guidance issued by the Treasury. Because the excise tax would be payable by us and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could reduce the cash available to complete a Business Combination and inhibit our ability to complete a Business Combination.
Results of Operations
As of March 31, 2023, we had not commenced any operations. All activity for the period from March 9, 2021 (inception) through March 31, 2023 relates to our formation and the Public Offering, and, since the closing of the Public Offering, a search for a Business Combination candidate. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after the completion of our initial Business Combination, at the earliest. We will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Public Offering. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.
For the three months ended March 31, 2023, we had net income of $562,788, which consisted of interest income earned on investments held in the Trust Account of $2,450,287 and the Company’s operating bank interest income of $8,133, partially offset by $928,000 of a change in fair value of warrant liability, operating costs amounting to $461,977 and provision for income tax of $505,655.
For the three months ended March 31, 2022, we had net income of $5,028,624, which consisted of $5,800,000 of a change in fair value of warrant liability, $20,880 interest income earned on investments held in the Trust Account and the Company’s operating bank interest account amounting to $25, partially offset by operating costs amounting to $792,281.
Contractual Obligations
We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities.
Administrative Services Agreement
We agreed to pay our Sponsor $10,000 per month for office space, utilities and secretarial and administrative support services. Upon the earlier of the completion of the initial Business Combination or our liquidation, we will cease paying such monthly fees. For the three months ended March 31, 2023 and 2022, $30,000 was incurred for the administrative service fee.
Registration Rights
The holders of the (i) founder shares, which were issued in a private placement prior to the closing of the Public Offering, (ii) Private Placement Warrants, which were issued in a private placement simultaneously with the closing of the Public Offering and the shares of Class A common stock underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of Working Capital Loans will have registration rights to require the Company to register a sale of any of the Company’s securities held by them pursuant to a registration rights agreement signed on the effective date of the Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The underwriters are entitled to a deferred underwriting discount of 3.5% or $8,050,000 of the gross proceeds of the Public Offering held in the Trust Account upon the completion of the Company’s initial Business Combination subject to the terms of the underwriting agreement.
Critical Accounting Policies and Estimates
We describe our significant accounting policies in Note 2—Significant Accounting Policies, of the Notes to Financial Statements included in this report. Our audited financial statements have been prepared in accordance with GAAP. Certain of our accounting policies require that the Company’s management apply significant judgments in defining the appropriate assumptions integral to financial estimates. On an ongoing basis, the Company’s management reviews the accounting policies, assumptions, estimates and judgments to ensure that our financial statements are presented fairly and in accordance with GAAP. Judgments are based on historical experience, terms of existing contracts, industry trends and information available from outside sources, as appropriate. However, by their nature, judgments are subject to an inherent degree of uncertainty, and, therefore, actual results could differ from our estimates.
20
Table of Contents
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
We are a smaller reporting company as defined by Rule 12b-2 under the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, such as this Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.
Our management evaluated, with the participation of our chief executive officer and chief financial officer (our “Certifying Officers”), the effectiveness of our disclosure controls and procedures as of March 31, 2023, pursuant to Rule 13a-15(b)under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that, as of March 31, 2023, our disclosure controls and procedures were effective.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
21
Table of Contents
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
None.
Item 1A. Risk Factors.
As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K filed with the SEC on March 31, 2023. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not Applicable.
Item 5. Other Information.
None.
22
Table of Contents
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
* | These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
23
Table of Contents
PART III. SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
DIRECT SELLING ACQUISITION CORP. | ||||||
Date: May 15, 2023 | /s/ Dave Wentz | |||||
Dave Wentz | ||||||
Chief Executive Officer |
24